KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Sep 2025 value amounting to $9.4 million.

  • Acadia Pharmaceuticals' Cash from Financing Activities rose 3416.04% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.2 million, marking a year-over-year increase of 183.08%. This contributed to the annual value of $6.8 million for FY2024, which is 72.76% down from last year.
  • According to the latest figures from Q3 2025, Acadia Pharmaceuticals' Cash from Financing Activities is $9.4 million, which was down 40.94% from $16.0 million recorded in Q2 2025.
  • Over the past 5 years, Acadia Pharmaceuticals' Cash from Financing Activities peaked at $16.0 million during Q2 2025, and registered a low of $268,000 during Q3 2024.
  • Over the past 3 years, Acadia Pharmaceuticals' median Cash from Financing Activities value was $3.6 million (recorded in 2024), while the average stood at $5.4 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Cash from Financing Activities soared by 4,342.86% in 2023 and then crashed by 97.90% in 2024.
  • Acadia Pharmaceuticals' Cash from Financing Activities (Quarterly) stood at $4.4 million in 2021, then plummeted by 63.02% to $1.6 million in 2022, then spiked by 236.68% to $5.4 million in 2023, then crashed by 63.77% to $2.0 million in 2024, then spiked by 3,416.04% to $9.4 million in 2025.
  • Its last three reported values are $9.4 million in Q3 2025, $16.0 million for Q2 2025, and $1.8 million during Q1 2025.